Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 38, 2012, Pages 9595-9602

  Lee, In Ah ^a   Hyam, Supriya R ^a   Jang, Se Eun ^a   Han, Myung Joo ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

ginsenoside Re; inflammation; lipopolysaccharide; macrophage; Toll like receptor 4

Indexed keywords

ALEXA FLUOR; ANTI-INFLAMMATORY EFFECTS; ARALIACEAE; GINSENOSIDE RB1; GINSENOSIDE RE; INFLAMMATION; LIPOPOLYSACCHARIDES; MURINE PERITONEAL MACROPHAGES; MYELOPEROXIDASE; OCCLUDIN; PANAX GINSENG; PEPTIDOGLYCANS; PERITONEAL MACROPHAGE; PROINFLAMMATORY CYTOKINES; SULFONIC ACID; SYSTEMIC INFLAMMATION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTORS;

DISEASES; MAMMALS; PATHOLOGY; PHOSPHORYLATION;

MACROPHAGES;

CYCLOOXYGENASE 2; GINSENOSIDE; GINSENOSIDE RE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; NONSTEROID ANTIINFLAMMATORY AGENT; NOS2 PROTEIN, MOUSE; PEPTIDOGLYCAN; PTGS2 PROTEIN, MOUSE; SMALL INTERFERING RNA; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; COLITIS; DRUG EFFECT; DRUG SCREENING; GENETICS; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; PHOSPHORYLATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS; CYCLOOXYGENASE 2; DRUG EVALUATION, PRECLINICAL; GINSENOSIDES; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED ICR; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDOGLYCAN; PHOSPHORYLATION; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 4; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

ALEXA; ARALIACEAE; MURINAE; MUS; PANAX GINSENG;

EID: 84866639068     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf301372g     Document Type: Article

References (32)

1. Johnson, L. N.; Koval, M. Cross-talk between pulmonary injury, oxidant stress, and gap junctional communication Antioxid. Redox Signal. 2009, 11, 355-367
2. Collins, T.; Read, M. A.; Neish, A. S.; Whitley, M. Z.; Thanos, D.; Maniatis, T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine inducible enhancers FASEB J. 1995, 9, 899-909
3. Baldwin, A. S., Jr. The NF-κB and IκB proteins: New discoveries and insights Annu. Rev. Immunol. 1996, 14, 649-681
4. David, H.; Masayuki, F.; Yasmin, G. H.; John, P. S.; Tyralee, G.; Junsuke, M.; Lory, A. H.; Ryan, C. U.; Anli, C.; Keith, J. B.; Ruliang, X.; Maria, T. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury Lab. Invest. 2010, 90, 1295-1305
5. Chow, J. C.; Young, D. W.; Golenbock, D. T.; Christ, W. J.; Gusovsky, F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction J. Biol. Chem. 1999, 274, 10689-10692
6. Ingalls, R. R.; Heine, H.; Lien, E.; Yoshimura, A.; Golenbock, D. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors Infect. Dis. Clin. North Am. 1999, 13, 341-53
7. Cario, E.; Pldolsky, D. K. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease Infect. Immun. 2000, 68, 7010-1017
8. O'Neill, L. A.; Dinarello, C. A. The IL-1 receptor/Toll-like receptor superfamily: Crucial receptors for inflammation and host defense Immunol. Today 2000, 21, 206-209
9. Hoshino, K.; Takeuchi, O.; Kawai, T.; Sanjo, H.; Ogawa, T.; Takeda, Y.; Takeda, K.; Akira, S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the LPS gene product J. Immunol. 1999, 162, 3749-52
10. Takeda, K.; Akira, S. TLR signaling pathways Semin. Immunol. 2004, 16, 3-9
11. Chan, M. M.; Huang, H. I.; Fenton, M. R.; Fong, D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties Biochem. Pharmacol. 1998, 55, 1955-1962
12. Paradkar, P. N.; Blum, P. S.; Berhow, M. A.; Baumann, H.; Kuo, S. M. Dietary isoflavones suppress endotoxin-induced inflammatory reaction in liver and intestine Cancer Lett. 2004, 215, 21-28
13. Davis, P. A.; Polagruto, J. A.; Valacchi, G.; Phung, A.; Soucek, K.; Keen, C. L.; Gershwin, M. M. Effects of apple extracts on NF-κB activation of human umbilical vein endothelial cells Exp. Biol. Med. (Maywood) 2006, 231, 594-598
14. Lee, I. A.; Park, Y. J.; Joh, E. H.; Kim, D. H. Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages J. Agric. Food Chem. 2011, 59, 13165-13172
15. Chao, L. K.; Liao, P. C.; Ho, C. L.; Wang, E. I.; Chuang, C. C.; Chiu, H. W.; Hung, L. B.; Hua, K. F. Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-κB pathway to reduce LPS-induced TNFα and NO expression J. Agric. Food Chem. 2010, 58, 3472-3478
16. Kim, D. H. Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng J. Ginseng Res. 2012, 36, 1-15
17. Park, E. K.; Shin, Y. W.; Lee, H. U.; Kim, S. S.; Lee, Y. C.; Lee, B. Y.; Kim, D. H. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide Biol. Pharm. Bull. 2005, 28, 652-6
18. Joh, E. H.; Lee, I. A.; Jung, I. H.; Kim, D. H. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-The key step of inflammation Biochem. Pharmacol. 2011, 82, 278-286
19. Bae, E. A.; Shin, J. E.; Kim, D. H. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect Biol. Pharm. Bull. 2005, 28, 1903-1908
20. Lee, I. A.; Hyun, Y. J.; Kim, D. H. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation Eur. J. Pharmacol. 2010, 648, 162-170
21. Shin, Y. W.; Kim, D. H. Antipruritic effect of ginsenoside rb1 and compound K in scratching behavior mouse models J. Pharmacol. Sci. 2005, 99, 83-88
22. Park, Y. J.; Liu, G.; Lorne, E. F.; Zhao, X.; Wang, J.; Tsuruta, Y.; Zmijewski, J.; Abraham, E. PAI-1 inhibits neutrophil efferocytosis Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 11784-11789
23. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1996, 72, 248-54
24. Shuto, T.; Xu, H.; Wang, B.; Han, J.; Kai, H.; G,u, X. X.; Murphy, T. F.; Lim, D. J.; Li, J. D. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by Toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells Proc. Natl. Acad. Sci. U.S.A. 2001, 17, 8774-8779
25. Sotolongo, J.; Ruiz, J.; Fukata, M. The role of innate immunity in the host defense against intestinal bacterial pathogens Curr. Infect. Dis. Rep. 2012, 14, 15-23
26. Astiz, M. E.; Rackow, E. C. Septic shock Lancet 1998, 351, 501-1505
27. Paul, S.; Shin, H. S.; Kang, S. C. Inhibition of inflammations and macrophage activation by ginsenoside-Re isolated from Korean ginseng (Panax ginseng C.A. Meyer) Food Chem. Toxicol. 2012, 50, 1354-1361
28. Park, E. K.; Choo, M. K.; Han, M. J.; Kim, D. H. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities Int. Arch. Allergy Immunol. 2004, 133, 113-10
29. Shin, Y. W.; Bae, E. A.; Kim, S. S.; Lee, Y. C.; Lee, B. Y.; Kim, D. H. The effects of ginsenoside Re and its metabolite, ginsenoside Rh1, on 12-O-tetradecanoylphorbol 13-acetate- and oxazolone-induced mouse dermatitis models Planta Med. 2006, 72, 376-378
30. Xu, Z.; Huang, C. X.; Li, Y.; Wang, P. Z.; Ren, G. L.; Chen, C. S.; Shang, F. J.; Zhang, Y.; Liu, Q. Q.; Jia, Z. S.; Nie, Q. H.; Sun, Y. T.; Bai, X. F. Toll-like receptor 4 siRNA attenuates LPS-induced secretion of inflammatory cytokines and chemokines by macrophages J. Infect. 2007, 55, e1-e9
31. Joh, E. H.; Gu, W.; Kim, D. H. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways Biochem. Pharmacol. 2012, 84, 331-340
32. Honda, H.; Nagai, Y.; Matsunaga, T.; Saitoh, S.; Akashi-Takamura, S.; Hayashi, H.; Fujii, I.; Miyake, K.; Muraguchi, A.; Takatsu, K. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor Toll-like receptor 4/MD-2 complex signaling in a different manner J. Leukocyte Biol. 2012, 91, 967-976